MassDevice

Abbott reports strong outcomes for next-gen Amulet LAA occlusion device

Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage ...
GlobalData on MSN

Abbott reports positive VERITAS study results for AFib

VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.
MedTech Dive

4 takeaways from the 2026 AF Symposium

Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...
MassDevice

The biggest cardiac tech news out of the 2026 AF Symposium

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.
Pharmabiz

Abbott announces positive results from VERITAS study of Amulet 360 LAA Occluder, a next-generation implant designed to reduce risk of stroke in patients with AFib

Abbott Park, Illinois Monday, February 9, 2026, 13:00 Hrs [IST] ...